LivaNova (LIVN) Stock Forecast, Price Target & Predictions
LIVN Stock Forecast
LivaNova stock forecast is as follows: an average price target of $71.25 (represents a 46.82% upside from LIVN’s last price of $48.53) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
LIVN Price Target
The average price target for LivaNova (LIVN) is $71.25 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $88.00 to $62.00. This represents a potential 46.82% upside from LIVN's last price of $48.53.
LIVN Analyst Ratings
According to 4 Wall Street analysts, LivaNova's rating consensus is 'Buy'. The analyst rating breakdown for LIVN stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
LivaNova Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | Rick Wise | Stifel Nicolaus | $72.00 | $53.45 | 34.71% | 48.36% |
| Jun 06, 2024 | Rick Wise | Stifel Nicolaus | $70.00 | $53.16 | 31.68% | 44.24% |
| Mar 20, 2024 | Rick Wise | Stifel Nicolaus | $65.00 | $56.63 | 14.78% | 33.94% |
| Dec 21, 2022 | - | Barclays | $62.00 | $56.05 | 10.62% | 27.76% |
| Nov 23, 2022 | - | Goldman Sachs | $63.00 | $53.95 | 16.77% | 29.82% |
| Aug 16, 2022 | - | Goldman Sachs | $73.00 | $63.86 | 14.31% | 50.42% |
| Aug 04, 2022 | - | Needham | $88.00 | $62.89 | 39.93% | 81.33% |
The latest LivaNova stock forecast, released on Jul 25, 2024 by Rick Wise from Stifel Nicolaus, set a price target of $72.00, which represents a 34.71% increase from the stock price at the time of the forecast ($53.45), and a 48.36% increase from LIVN last price ($48.53).
LivaNova Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 3 |
| Avg Price Target | - | $72.00 | $69.00 |
| Last Closing Price | $48.53 | $48.53 | $48.53 |
| Upside/Downside | -100.00% | 48.36% | 42.18% |
In the current month, the average price target of LivaNova stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to LivaNova's last price of $48.53. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Feb 21, 2024 | Needham | Buy | Buy | Hold |
| Feb 20, 2024 | Mizuho Securities | - | Buy | Upgrade |
| Oct 23, 2023 | Needham | Buy | Buy | Hold |
| Dec 21, 2022 | Barclays | - | Equal-Weight | Initialise |
| Nov 23, 2022 | Goldman Sachs | Buy | Buy | Hold |
| Aug 16, 2022 | Goldman Sachs | Buy | Buy | Hold |
| Aug 04, 2022 | Needham | Buy | Buy | Hold |
| Feb 24, 2022 | Needham | Buy | Buy | Hold |
LivaNova's last stock rating was published by Needham on Feb 21, 2024. The company gave LIVN a "Buy" rating, the same as its previous rate.
LivaNova Financial Forecast
LivaNova Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $310.10M | $286.11M | $293.90M | $263.40M | $274.90M | $252.60M | - | $240.18M | $270.06M | $253.22M | $264.48M | $247.60M | $269.56M | $240.08M | $182.21M | $242.40M | $287.59M | $268.61M |
| Avg Forecast | $351.32M | $331.43M | $351.58M | $325.00M | $335.61M | $314.04M | $335.14M | $307.21M | $319.84M | $299.30M | $304.78M | $278.17M | $287.71M | $271.97M | $265.05M | $243.33M | $262.29M | $246.99M | $249.55M | $231.56M | $267.21M | $246.20M | $244.09M | $232.32M | $268.81M | $218.55M | $169.74M | $244.11M | $295.49M | $273.42M |
| High Forecast | $353.25M | $333.25M | $353.52M | $326.79M | $337.46M | $315.77M | $336.99M | $308.91M | $321.60M | $301.91M | $306.46M | $279.70M | $289.83M | $282.50M | $266.51M | $244.67M | $263.73M | $248.35M | $249.55M | $235.53M | $271.79M | $250.42M | $248.28M | $236.30M | $273.41M | $222.30M | $172.64M | $248.29M | $300.55M | $278.10M |
| Low Forecast | $346.80M | $327.17M | $347.06M | $320.82M | $331.29M | $310.00M | $330.83M | $303.26M | $315.72M | $296.79M | $300.86M | $274.59M | $285.86M | $267.18M | $261.64M | $240.20M | $258.91M | $243.81M | $249.55M | $228.63M | $263.83M | $243.08M | $241.01M | $229.38M | $265.41M | $215.79M | $167.59M | $241.02M | $291.75M | $269.96M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.05% | 1.11% | 1.08% | 1.05% | 1.02% | - | 1.04% | 1.01% | 1.03% | 1.08% | 1.07% | 1.00% | 1.10% | 1.07% | 0.99% | 0.97% | 0.98% |
LivaNova's average Quarter revenue forecast for Mar 24 based on 1 analysts is $278.17M, with a low forecast of $274.59M, and a high forecast of $279.70M. LIVN's average Quarter revenue forecast represents a -10.30% decrease compared to the company's last Quarter revenue of $310.10M (Dec 23).
LivaNova EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-88.00M | $4.46M | $17.40M | $12.70M | $29.14M | $11.22M | - | $24.25M | $99.15M | $-26.12M | $-18.28M | $23.44M | $-13.73M | $18.09M | $11.36M | $22.87M | $58.88M | $21.09M |
| Avg Forecast | $33.26M | $31.38M | $33.29M | $30.77M | $31.78M | $29.74M | $31.73M | $29.09M | $30.28M | $28.34M | $28.86M | $34.02M | $27.24M | $25.75M | $25.10M | $30.93M | $24.83M | $-7.52M | $23.63M | $28.11M | $15.58M | $-6.83M | $-7.54M | $5.72M | $-242.69M | $14.23M | $8.77M | $18.22M | $-121.59M | $42.10M |
| High Forecast | $33.45M | $31.55M | $33.47M | $30.94M | $31.95M | $29.90M | $31.91M | $29.25M | $30.45M | $28.59M | $29.02M | $40.82M | $27.44M | $26.75M | $25.23M | $37.11M | $24.97M | $-6.01M | $23.63M | $33.74M | $18.70M | $-5.47M | $-6.03M | $6.86M | $-194.16M | $17.07M | $10.53M | $21.86M | $-97.28M | $50.52M |
| Low Forecast | $32.84M | $30.98M | $32.86M | $30.38M | $31.37M | $29.35M | $31.32M | $28.71M | $29.89M | $28.10M | $28.49M | $27.21M | $27.07M | $25.30M | $24.77M | $24.74M | $24.52M | $-9.02M | $23.63M | $22.49M | $12.47M | $-8.20M | $-9.05M | $4.58M | $-291.23M | $11.38M | $7.02M | $14.57M | $-145.91M | $33.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.23% | 0.17% | 0.69% | 0.41% | 1.17% | -1.49% | - | 0.86% | 6.36% | 3.82% | 2.43% | 4.10% | 0.06% | 1.27% | 1.29% | 1.26% | -0.48% | 0.50% |
3 analysts predict LIVN's average Quarter EBITDA for Dec 23 to be $27.24M, with a high of $27.44M and a low of $27.07M. This is 511.09% upper than LivaNova's previous annual EBITDA (Sep 23) of $4.46M.
LivaNova Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $16.30M | $-7.32M | $1.20M | $7.40M | $1.70M | $-107.40M | - | $2.99M | $-8.53M | $-42.21M | $-55.28M | $-29.66M | $-279.29M | $-14.72M | $-87.95M | $37.58M | $-143.42M | $32.12M |
| Avg Forecast | $58.63M | $50.37M | $56.22M | $52.11M | $52.68M | $44.40M | $55.50M | $43.13M | $42.65M | $38.90M | $42.75M | $3.62M | $42.04M | $34.73M | $29.45M | $3.29M | $39.99M | $-24.99M | $27.90M | $2.99M | $-7.74M | $-22.71M | $-22.82M | $-23.40M | $-258.63M | $-11.86M | $-118.79M | $46.32M | $-140.31M | $28.26M |
| High Forecast | $59.05M | $50.73M | $56.62M | $52.49M | $53.06M | $44.72M | $55.90M | $43.44M | $42.95M | $39.44M | $43.06M | $4.35M | $45.76M | $40.16M | $29.66M | $3.95M | $40.27M | $-19.99M | $27.90M | $3.59M | $-6.19M | $-18.17M | $-18.25M | $-18.72M | $-206.90M | $-9.49M | $-95.03M | $55.59M | $-112.25M | $33.92M |
| Low Forecast | $57.64M | $49.53M | $55.28M | $51.24M | $51.80M | $43.66M | $54.57M | $42.41M | $41.94M | $38.25M | $42.04M | $2.90M | $39.37M | $32.02M | $28.95M | $2.63M | $39.32M | $-29.98M | $27.90M | $2.39M | $-9.29M | $-27.26M | $-27.38M | $-28.08M | $-310.35M | $-14.23M | $-142.55M | $37.06M | $-168.37M | $22.61M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.39% | -0.21% | 0.04% | 2.25% | 0.04% | 4.30% | - | 1.00% | 1.10% | 1.86% | 2.42% | 1.27% | 1.08% | 1.24% | 0.74% | 0.81% | 1.02% | 1.14% |
LivaNova's average Quarter net income forecast for Mar 24 is $3.62M, with a range of $2.90M to $4.35M. LIVN's average Quarter net income forecast represents a -77.78% decrease compared to the company's last Quarter net income of $16.30M (Dec 23).
LivaNova SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $133.30M | $134.79M | $125.90M | $124.10M | $119.60M | $114.63M | - | $118.53M | $124.43M | $109.04M | $122.75M | $112.62M | $110.35M | $99.20M | $98.05M | $120.18M | $130.61M | $123.02M |
| Avg Forecast | $160.85M | $151.74M | $160.97M | $148.80M | $153.66M | $143.78M | $153.44M | $140.66M | $146.43M | $137.03M | $139.54M | $143.42M | $131.73M | $124.52M | $121.35M | $130.38M | $120.09M | $64.50M | $114.25M | $118.53M | $112.47M | $58.64M | $50.63M | $88.73M | $101.99M | $79.64M | $132.36M | $160.78M | $138.41M | $118.06M |
| High Forecast | $161.73M | $152.58M | $161.86M | $149.62M | $154.50M | $144.57M | $154.29M | $141.43M | $147.24M | $138.23M | $140.31M | $172.10M | $132.70M | $129.34M | $122.02M | $156.45M | $120.75M | $77.41M | $114.25M | $142.23M | $134.96M | $70.37M | $60.76M | $106.48M | $122.38M | $95.57M | $158.84M | $192.94M | $166.09M | $141.67M |
| Low Forecast | $158.78M | $149.79M | $158.90M | $146.89M | $151.68M | $141.93M | $151.47M | $138.85M | $144.55M | $135.88M | $137.75M | $114.73M | $130.88M | $122.33M | $119.79M | $104.30M | $118.54M | $51.60M | $114.25M | $94.82M | $89.97M | $46.91M | $40.51M | $70.98M | $81.59M | $63.71M | $105.89M | $128.62M | $110.73M | $94.45M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.08% | 1.04% | 0.95% | 1.00% | 1.78% | - | 1.00% | 1.11% | 1.86% | 2.42% | 1.27% | 1.08% | 1.25% | 0.74% | 0.75% | 0.94% | 1.04% |
LivaNova's average Quarter SG&A projection for Mar 24 is $143.42M, based on 1 Wall Street analysts, with a range of $114.73M to $172.10M. The forecast indicates a 7.59% rise compared to LIVN last annual SG&A of $133.30M (Dec 23).
LivaNova EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 6 | 10 | 10 | 10 | 10 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.30 | $-0.14 | $0.02 | $0.14 | $0.03 | $-2.01 | - | $0.06 | $-0.16 | $-0.82 | $-1.13 | $-0.61 | $-5.75 | $-0.30 | $-1.81 | $0.78 | $-2.96 | $0.66 |
| Avg Forecast | $1.07 | $0.92 | $1.03 | $0.95 | $0.96 | $0.81 | $1.02 | $0.79 | $0.78 | $0.71 | $0.78 | $0.49 | $0.77 | $0.64 | $0.54 | $0.39 | $0.73 | $0.55 | $0.52 | $0.48 | $0.52 | $0.45 | $0.33 | $0.15 | $0.68 | $0.20 | $-0.30 | $0.43 | $0.98 | $0.75 |
| High Forecast | $1.08 | $0.93 | $1.04 | $0.96 | $0.97 | $0.82 | $1.02 | $0.80 | $0.79 | $0.72 | $0.79 | $0.49 | $0.84 | $0.74 | $0.54 | $0.40 | $0.74 | $0.55 | $0.52 | $0.49 | $0.53 | $0.46 | $0.34 | $0.16 | $0.69 | $0.21 | $-0.29 | $0.44 | $1.00 | $0.77 |
| Low Forecast | $1.06 | $0.91 | $1.01 | $0.94 | $0.95 | $0.80 | $1.00 | $0.78 | $0.77 | $0.70 | $0.77 | $0.48 | $0.72 | $0.59 | $0.53 | $0.39 | $0.72 | $0.54 | $0.52 | $0.47 | $0.51 | $0.44 | $0.32 | $0.15 | $0.66 | $0.20 | $-0.30 | $0.42 | $0.96 | $0.74 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.39% | -0.22% | 0.04% | 0.36% | 0.04% | -3.68% | - | 0.12% | -0.31% | -1.84% | -3.44% | -3.96% | -8.51% | -1.48% | 6.12% | 1.81% | -3.04% | 0.88% |
According to 1 Wall Street analysts, LivaNova's projected average Quarter EPS for Mar 24 is $0.49, with a low estimate of $0.48 and a high estimate of $0.49. This represents a 62.08% increase compared to LIVN previous annual EPS of $0.30 (Dec 23).
LivaNova Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ATEC | Alphatec | $5.59 | $16.64 | 197.67% | Buy |
| IRTC | iRhythm | $76.61 | $144.20 | 88.23% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| FNA | Paragon 28 | $7.39 | $11.50 | 55.62% | Buy |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
| CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
| SIBN | SI-BONE | $15.73 | $20.00 | 27.15% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| GMED | Globus Medical | $69.75 | $79.54 | 14.04% | Buy |
| BRKR | Bruker | $65.66 | $71.67 | 9.15% | Buy |
| ITGR | Integer | $126.78 | $131.00 | 3.33% | Buy |
| GKOS | Glaukos | $126.28 | $101.56 | -19.58% | Buy |
LIVN Forecast FAQ
Is LivaNova a good buy?
Yes, according to 4 Wall Street analysts, LivaNova (LIVN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of LIVN's total ratings.
What is LIVN's price target?
LivaNova (LIVN) average price target is $71.25 with a range of $62 to $88, implying a 46.82% from its last price of $48.53. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will LivaNova stock go up soon?
According to Wall Street analysts' prediction for LIVN stock, the company can go up by 46.82% (from the last price of $48.53 to the average price target of $71.25), up by 81.33% based on the highest stock price target, and up by 27.76% based on the lowest stock price target.
Can LivaNova stock reach $70?
LIVN's average twelve months analyst stock price target of $71.25 supports the claim that LivaNova can reach $70 in the near future.
What are LivaNova's analysts' financial forecasts?
LivaNova's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.29B (high $1.3B, low $1.28B), average EBITDA is $122.33M (high $123.01M, low $120.76M), average net income is $195.71M (high $197.11M, low $192.44M), average SG&A $591.54M (high $594.8M, low $583.93M), and average EPS is $3.58 (high $3.61, low $3.53). LIVN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.36B (high $1.37B, low $1.34B), average EBITDA is $128.71M (high $129.42M, low $127.05M), average net income is $217.33M (high $218.88M, low $213.69M), average SG&A $622.36M (high $625.79M, low $614.35M), and average EPS is $3.98 (high $4.01, low $3.91).
Did the LIVN's actual financial results beat the analysts' financial forecasts?
Based on LivaNova's last annual report (Dec 2023), the company's revenue was $1.15B, beating the average analysts forecast of $1.07B by 8.00%. Apple's EBITDA was $59.4M, missing the average prediction of $109.02M by -45.51%. The company's net income was $17.5M, missing the average estimation of $109.51M by -84.02%. Apple's SG&A was $518.1M, beating the average forecast of $507.98M by 1.99%. Lastly, the company's EPS was $0.32, missing the average prediction of $2.34 by -86.32%. In terms of the last quarterly report (Dec 2023), LivaNova's revenue was $310.1M, beating the average analysts' forecast of $287.71M by 7.78%. The company's EBITDA was $-88M, missing the average prediction of $27.24M by -423.03%. LivaNova's net income was $16.3M, missing the average estimation of $42.04M by -61.22%. The company's SG&A was $133.3M, beating the average forecast of $131.73M by 1.19%. Lastly, the company's EPS was $0.3, missing the average prediction of $0.77 by -61.04%